{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:57:36Z","timestamp":1761101856897},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2009,5,20]],"date-time":"2009-05-20T00:00:00Z","timestamp":1242777600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J GEN INTERN MED"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1007\/s11606-009-1009-6","type":"journal-article","created":{"date-parts":[[2009,5,19]],"date-time":"2009-05-19T16:25:14Z","timestamp":1242750314000},"page":"822-828","source":"Crossref","is-referenced-by-count":43,"title":["Guidelines for Genetic Risk Assessment of Hereditary Breast and Ovarian Cancer: Early Disagreements and Low Utilization"],"prefix":"10.1007","volume":"24","author":[{"given":"Douglas E.","family":"Levy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judy E.","family":"Garber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra E.","family":"Shields","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,5,20]]},"reference":[{"issue":"12","key":"1009_CR1","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1200\/JCO.2003.03.189","volume":"21","author":"American Society of Clinical Oncology","year":"2003","unstructured":"American Society of Clinical Oncology. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility. J Clin Oncol. 2003;21(12):2397\u2013406.","journal-title":"J Clin Oncol"},{"key":"1009_CR2","unstructured":"National Comprehensive Cancer Network. Genetic\/Familial High-Risk Assessment: Breast and Ovarian V.1.2007. Fort Washington, PA; 2007."},{"issue":"5","key":"1009_CR3","doi-asserted-by":"crossref","first-page":"355","DOI":"10.7326\/0003-4819-143-5-200509060-00011","volume":"143","author":"US Preventive Services Taskforce","year":"2005","unstructured":"US Preventive Services Taskforce. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement. Ann Intern Med. 2005;143(5):355\u201361.","journal-title":"Ann Intern Med"},{"key":"1009_CR4","unstructured":"Myriad Genetics. Myriad Genetics Awarded Three US Patents And Eight International Patents. Salt Lake City, UT; 2001:News release."},{"issue":"2","key":"1009_CR5","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1200\/JCO.2005.10.042","volume":"23","author":"JE Garber","year":"2005","unstructured":"Garber JE, Offit K. Hereditary cancer predisposition syndromes. J Clin Oncol. 2005;23(2):276\u201392.","journal-title":"J Clin Oncol"},{"issue":"8","key":"1009_CR6","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.humpath.2005.06.006","volume":"36","author":"J Prat","year":"2005","unstructured":"Prat J, Ribe A, Gallardo A. Hereditary ovarian cancer. Hum Pathol. 2005;36(8):861\u201370.","journal-title":"Hum Pathol"},{"key":"1009_CR7","unstructured":"American Cancer Society. Leading sites of new cancer cases and deaths\u20142008 estimates.; 2008."},{"issue":"5","key":"1009_CR8","doi-asserted-by":"crossref","first-page":"362","DOI":"10.7326\/0003-4819-143-5-200509060-00012","volume":"143","author":"HD Nelson","year":"2005","unstructured":"Nelson HD, Huffman LH, Fu R, Harris EL. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: systematic evidence review for the US Preventive Services Task Force. Ann Intern Med. 2005;143(5):362\u201379.","journal-title":"Ann Intern Med"},{"issue":"5","key":"1009_CR9","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/375033","volume":"72","author":"A Antoniou","year":"2003","unstructured":"Antoniou A, Pharoah PD, Narod S, et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet. 2003;72(5):1117\u201330.","journal-title":"Am J Hum Genet"},{"issue":"3","key":"1009_CR10","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S1470-2045(06)70585-X","volume":"7","author":"SM Domchek","year":"2006","unstructured":"Domchek SM, Friebel TM, Neuhausen SL, et al. Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study. Lancet Oncol. 2006;7(3):223\u20139.","journal-title":"Lancet Oncol"},{"issue":"3","key":"1009_CR11","first-page":"505","volume":"60","author":"D Abeliovich","year":"1997","unstructured":"Abeliovich D, Kaduri L, Lerer I, et al. The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women. Am J Hum Genet. 1997;60(3):505\u201314.","journal-title":"Am J Hum Genet"},{"issue":"6","key":"1009_CR12","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1200\/JCO.2002.20.6.1480","volume":"20","author":"TS Frank","year":"2002","unstructured":"Frank TS, Deffenbaugh AM, Reid JE, et al. Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals. J Clin Oncol. 2002;20(6):1480\u201390.","journal-title":"J Clin Oncol"},{"issue":"5","key":"1009_CR13","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1200\/JCO.1996.14.5.1730","volume":"14","author":"American Society of Clinical Oncology","year":"1996","unstructured":"American Society of Clinical Oncology. Statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility, Adopted on February 20, 1996. J Clin Oncol. 1996;14(5):1730\u20136; discussion 1737-40.","journal-title":"J Clin Oncol"},{"issue":"11A","key":"1009_CR14","first-page":"161","volume":"13","author":"M Daly","year":"1999","unstructured":"Daly M. NCCN Practice Guidelines: Genetics\/Familial High-Risk Cancer Screening. Oncology. 1999;13(11A):161\u2013183.","journal-title":"Oncology"},{"key":"1009_CR15","unstructured":"American College of Medical Genetics Foundation. Genetic Susceptibility to Breast and Ovarian Cancer: Assessment, Counseling and Testing Guidelines. 1999."},{"issue":"1","key":"1009_CR16","first-page":"99","volume":"59","author":"TC Rosenthal","year":"1999","unstructured":"Rosenthal TC, Puck SM. Screening for genetic risk of breast cancer. Am Fam Physician. 1999;59(1):99\u2013104, 106.","journal-title":"Am Fam Physician"},{"key":"1009_CR17","unstructured":"Birkhead GS. Letter to physicians: Genetic Testing for BRCA1 and BRCA2: Information for Health Care Professionals, NYS Dept. of Health, Center for Community Health, August 22, 2007."},{"issue":"7","key":"1009_CR18","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1093\/aje\/kwh090","volume":"159","author":"G Zou","year":"2004","unstructured":"Zou G. A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol. 2004;159(7):702\u20136.","journal-title":"Am J Epidemiol"},{"key":"1009_CR19","doi-asserted-by":"crossref","unstructured":"McClain MR, Palomaki GE, Hampel H, Westman JA, Haddow JE. Screen positive rates among six family history screening protocols for breast\/ovarian cancer in four cohorts of women. Fam Cancer. 2008.","DOI":"10.1007\/s10689-008-9188-6"},{"issue":"5","key":"1009_CR20","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1200\/JCO.2002.20.5.1260","volume":"20","author":"L Scheuer","year":"2002","unstructured":"Scheuer L, Kauff N, Robson M, et al. Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers. J Clin Oncol. 2002;20(5):1260\u20138.","journal-title":"J Clin Oncol"},{"issue":"15","key":"1009_CR21","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1001\/jama.282.15.1458","volume":"282","author":"MD Cabana","year":"1999","unstructured":"Cabana MD, Rand CS, Powe NR, et al. Why don\u2019t physicians follow clinical practice guidelines? A framework for improvement. Jama. 1999;282(15):1458\u201365.","journal-title":"Jama"},{"issue":"6","key":"1009_CR22","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1097\/01.GIM.0000093979.08524.86","volume":"5","author":"J Mouchawar","year":"2003","unstructured":"Mouchawar J, Valentine Goins K, Somkin C, et al. Guidelines for breast and ovarian cancer genetic counseling referral: adoption and implementation in HMOs. Genet Med. 2003;5(6):444\u201350.","journal-title":"Genet Med"},{"issue":"2","key":"1009_CR23","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1525-1497.2005.30429.x","volume":"20","author":"AE Shields","year":"2005","unstructured":"Shields AE, Blumenthal D, Weiss KB, Comstock CB, Currivan D, Lerman C. Barriers to translating emerging genetic research on smoking into clinical practice. Perspectives of primary care physicians. J Gen Intern Med. 2005;20(2):131\u20138.","journal-title":"J Gen Intern Med"},{"issue":"2","key":"1009_CR24","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/01.GIM.0000055201.16487.61","volume":"5","author":"S Suther","year":"2003","unstructured":"Suther S, Goodson P. Barriers to the provision of genetic services by primary care physicians: a systematic review of the literature. Genet Med. 2003;5(2):70\u20136.","journal-title":"Genet Med"},{"issue":"10","key":"1009_CR25","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1136\/jmg.2004.030296","volume":"42","author":"L Wideroff","year":"2005","unstructured":"Wideroff L, Vadaparampil ST, Greene MH, Taplin S, Olson L, Freedman AN. Hereditary breast\/ovarian and colorectal cancer genetics knowledge in a national sample of US physicians. J Med Genet. 2005;42(10):749\u201355.","journal-title":"J Med Genet"},{"issue":"5","key":"1009_CR26","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.cdp.2007.08.003","volume":"31","author":"SA Sabatino","year":"2007","unstructured":"Sabatino SA, McCarthy EP, Phillips RS, Burns RB. Breast cancer risk assessment and management in primary care: provider attitudes, practices, and barriers. Cancer Detect Prev. 2007;31(5):375\u201383.","journal-title":"Cancer Detect Prev"},{"key":"1009_CR27","unstructured":"US task force clarifies who should be screened for BRCA mutations. Reuters Health Medical News 2005 September 6, 2005."},{"key":"1009_CR28","unstructured":"Bristol N. High-Risk Testing. The Washington Post 2005 September 27, 2005;F02."},{"key":"1009_CR29","unstructured":"McCullough M. Breast cancer tests get new guidelines. Philadelphia Inquirer 2005 September 7, 2005;A03."},{"key":"1009_CR30","unstructured":"Rubin R. Genetic predisposition is reason to screen, new guidelines say. USA Today 2005 September 6, 2005;7D."},{"issue":"3","key":"1009_CR31","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1056\/NEJM200101183440307","volume":"344","author":"D Mechanic","year":"2001","unstructured":"Mechanic D, McAlpine DD, Rosenthal M. Are patients\u2019 office visits with physicians getting shorter? N Engl J Med. 2001;344(3):198\u2013204.","journal-title":"N Engl J Med"},{"issue":"5","key":"1009_CR32","doi-asserted-by":"crossref","first-page":"388","DOI":"10.7326\/0003-4819-143-5-200509060-00015","volume":"143","author":"W Burke","year":"2005","unstructured":"Burke W. Taking family history seriously. Ann Intern Med. 2005;143(5):388\u20139.","journal-title":"Ann Intern Med"},{"key":"1009_CR33","doi-asserted-by":"crossref","unstructured":"Blumenthal D. Stimulating the Adoption of Health Information Technology. N Engl J Med. 2009.","DOI":"10.1056\/NEJMp0901592"},{"issue":"10","key":"1009_CR34","doi-asserted-by":"crossref","first-page":"742","DOI":"10.7326\/0003-4819-144-10-200605160-00125","volume":"144","author":"B Chaudhry","year":"2006","unstructured":"Chaudhry B, Wang J, Wu S, et al. Systematic review: impact of health information technology on quality, efficiency, and costs of medical care. Ann Intern Med. 2006;144(10):742\u201352.","journal-title":"Ann Intern Med"},{"key":"1009_CR35","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1056\/NEJMsa0802005","volume":"359","author":"C DesRoches","year":"2008","unstructured":"DesRoches C, Campbell E, Rao S, et al. Electronic health records in ambulatory care - a national survey of physicians. N Engl J Med. 2008;359:50\u201360.","journal-title":"N Engl J Med"},{"issue":"7252","key":"1009_CR36","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1136\/bmj.321.7252.28","volume":"321","author":"J Emery","year":"2000","unstructured":"Emery J, Walton R, Murphy M, et al. Computer support for interpreting family histories of breast and ovarian cancer in primary care: comparative study with simulated cases. Bmj. 2000;321(7252):28\u201332.","journal-title":"Bmj"},{"issue":"7494","key":"1009_CR37","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1136\/bmj.38398.500764.8F","volume":"330","author":"K Kawamoto","year":"2005","unstructured":"Kawamoto K, Houlihan CA, Balas EA, Lobach DF. Improving clinical practice using clinical decision support systems: a systematic review of trials to identify features critical to success. Bmj. 2005;330(7494):765.","journal-title":"Bmj"},{"key":"1009_CR38","unstructured":"Qureshi N, Wilson B, Santaguida P, et al. Collection and use of cancer family history in primary care. Evid Rep Technol Assess (Full Rep). 2007;(159):1\u201384."},{"issue":"14","key":"1009_CR39","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1001\/jama.293.14.1729","volume":"293","author":"K Armstrong","year":"2005","unstructured":"Armstrong K, Micco E, Carney A, Stopfer J, Putt M. Racial differences in the use of BRCA1\/2 testing among women with a family history of breast or ovarian cancer. Jama. 2005;293(14):1729\u201336.","journal-title":"Jama"},{"issue":"2","key":"1009_CR40","first-page":"96","volume":"12","author":"K Gwyn","year":"2003","unstructured":"Gwyn K, Vernon SW, Conoley PM. Intention to pursue genetic testing for breast cancer among women due for screening mammography. Cancer Epidemiol Biomarkers Prev. 2003;12(2):96\u2013102.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"1009_CR41","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/01.GIM.0000056829.76915.2A","volume":"5","author":"K Armstrong","year":"2003","unstructured":"Armstrong K, Weiner J, Weber B, Asch DA. Early adoption of BRCA1\/2 testing: who and why. Genet Med. 2003;5(2):92\u20138.","journal-title":"Genet Med"},{"issue":"12","key":"1009_CR42","first-page":"1579","volume":"11","author":"HS Thompson","year":"2002","unstructured":"Thompson HS, Valdimarsdottir HB, Duteau-Buck C, et al. Psychosocial predictors of BRCA counseling and testing decisions among urban African-American women. Cancer Epidemiol Biomarkers Prev. 2002;11(12):1579\u201385.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"5","key":"1009_CR43","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/01.GIM.0000162874.58370.C0","volume":"7","author":"MA Hall","year":"2005","unstructured":"Hall MA, McEwen JE, Barton JC, et al. Concerns in a primary care population about genetic discrimination by insurers. Genet Med. 2005;7(5):311\u20136.","journal-title":"Genet Med"},{"issue":"5","key":"1009_CR44","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1200\/JCO.1998.16.5.1650","volume":"16","author":"C Lerman","year":"1998","unstructured":"Lerman C, Hughes C, Lemon SJ, et al. What you don\u2019t know can hurt you: adverse psychologic effects in members of BRCA1-linked and BRCA2-linked families who decline genetic testing. J Clin Oncol. 1998;16(5):1650\u20134.","journal-title":"J Clin Oncol"},{"issue":"2","key":"1009_CR45","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/00125817-200103000-00005","volume":"3","author":"CM Velicer","year":"2001","unstructured":"Velicer CM, Taplin S. Genetic testing for breast cancer: where are health care providers in the decision process? Genet Med. 2001;3(2):112\u20139.","journal-title":"Genet Med"},{"key":"1009_CR46","unstructured":"Johnson A. Genetic privacy. Genetics Brief. 2002(4)."},{"issue":"3","key":"1009_CR47","first-page":"317","volume":"39","author":"WF Mulholland","year":"1999","unstructured":"Mulholland WF, Jaeger AS. Genetic privacy and discrimination: a survey of state legislation. Comment. Jurimetrics. 1999;39(3):317\u201326.","journal-title":"Comment. Jurimetrics"}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-009-1009-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11606-009-1009-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-009-1009-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T17:32:42Z","timestamp":1559410362000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11606-009-1009-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5,20]]},"references-count":47,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["1009"],"URL":"https:\/\/doi.org\/10.1007\/s11606-009-1009-6","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"value":"0884-8734","type":"print"},{"value":"1525-1497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,5,20]]}}}